GLIB L. SAVYCH

**** ***** ****** *****, ***. *, Arlington, VA 22204 • ac10yj@r.postjobfree.com • 919-***-**** D.C. Bar candidate, July 2017 • Patent Bar anticipated, September 2017 EDUCATION

George Mason University School of Law, Arlington, VA Juris Doctor, Patent Law Track, cum laude, May 2017 Class Rank: Top 21%; GPA: 3.60

Activities: George Mason Law Review, Associate Editor Intellectual Property Law Society, Vice President

Patent Applications Preparation Clinic, Spring 2017 Pauline Newman IP American Inn of Court, student member, 2014-15 University of Amsterdam, Amsterdam, the Netherlands Master of Science in Biomedical Sciences, cum laude, January 2009 Honors: Huygens Scholar, 2007

Master’s Theses: Optimization of the retroviral gene transfer system for rapid transgenesis in murine hematopoietic compartment.

Characterization of novel regulators of TRAIL-mediated apoptosis in cancer cells. North Carolina State University, Raleigh, NC

Bachelor of Science in Biological Sciences, magna cum laude, December 2005 Activities: Dr. Greg Gibson Lab, Department of Genetics, Research Assistant, May 2004 – May 2005 Worked full-time as a server to pay all college and living expenses. EXPERIENCE

Birch, Stewart, Kolasch & Birch, LLP, Falls Church, VA September 2015 – July 2017 IP Law Clerk

Drafted responses to USPTO office actions and client letters proposing patent prosecution strategies. Drafted training materials for the firm’s educational seminars on patent prosecution, post-grant proceedings, and trademarks. Researched topics in patent and trademark law. Center for the Protection of Intellectual Property, George Mason University School of Law, Arlington, VA Research Assistant May – August 2015

Analyzed and summarized research papers on current intellectual property issues such as royalty stacking, patent enforcement values, and effects of copyright on diversity of creative output. Bancroft, McGavin, Horvath & Judkins, PC, Fairfax, VA May – August 2015 Legal Intern

Researched and drafted briefs on topics including insurance law, arbitration, and civil actions for hate crimes. Conducted fact research for an international defamation case. Observed trials and motion hearings. University of North Carolina at Chapel Hill, Chapel Hill, NC November 2012 – August 2014 Research Specialist, Pre-clinical Genomic Pathology Core, Lineberger Cancer Center Developed operating procedures for a high-throughput automated pipeline for sequencing tumor and normal genomes of cancer patients to discover mutations targetable by drugs. Implemented mass spectrometry instrumentation for patient identity confirmation. University of North Carolina at Chapel Hill, Chapel Hill, NC July 2009 – November 2012 Lab Manager, Dr. Derek Chiang Lab, Lineberger Cancer Center Executed lab start-up including purchasing and installing equipment and supplies and ensuring compliance with safety regulations. Designed and carried out experiments to identify mutations in liver cancer utilizing genomic, molecular, and cell biology techniques such as genome sequencing, RNA interference, and cell- based assays.

LANGUAGE SKILLS, ACTIVITIES, AND INTERESTS

Fluent in Ukrainian and Russian.

Side-by-Side LGBT film festival, St. Petersburg, Russia, volunteer translator, 2013 – 2015. Traveled extensively through Europe; avid art admirer and museumgoer. Glib L. Savych

Page 2

PUBLICATIONS

Sean P. Cleary, William R. Jeck, Xiaobei Zhao, Sara R. Selitsky, Gleb L. Savich,1 Ting-Xu Tan, Michael C. Wu, Yun Li, Michael Lawrence, Gad Getz, Jinyu Li, Scott Powers, Hyeja Kim, Sandra Fischer, Maha Giundi, Anand Ghanekar, Derek Y. Chiang. Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology. Nov. 2013, 58(5):1693-1702. Wang P, Dong Q, Zhang C, Kuan PF, Liu Y, Jeck WR, Andersen JB, Jiang W, Savich GL, Tan TX, Auman JT, Hoskins JM, Misher AD, Moser CD, Yourstone SM, Kim JW, Cibulskis K, Getz G, Hunt HV, Thorgeirsson SS, Roberts LR, Ye D, Guan KL, Xiong Y, Qin LX, Chiang DY. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene. June 2013, 32(25):3091-100. Aziz M Mezlini, Eric JM Smith, Marc Fiume, Orion Buske, Gleb Savich, Sohrab Shah, Sam Aparicion, Derek Chiang, Anna Goldenberg, and Michael Brudno. iReckon: Simultaneous isoform discovery and abundance estimation from RNA-seq data. Genome Res. March 2013, 23(3):519-29. Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, Savich GL, He X, Mieczkowski P, Grimm SA, Perou CM, MacLeod JN, Chiang DY, Prins JF, Liu J. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. Oct. 2010; 38(18):e178. Maas C, Verbrugge I, de Vries E, Savich G, van de Kooij LW, Tait SW, Borst J. Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation. Cell Death Differ. Oct. 2010; 17(10):1613-23. 1 Alternative name spelling